Elaine Sun

Elaine Sun

Director/Board Member at RECURSION PHARMACEUTICALS, INC.

Net worth: 83 252 $ as of 30/05/2026

55 year
Health Technology
Finance
Consumer Services

Profile

Elaine D. Sun occupies the position of Chief Financial Officer & Senior Vice President at Halozyme Therapeutics, Inc. Ms. Sun is also on the board of Cirius Therapeutics, Inc. In the past Ms. Sun was Chief Financial & Strategy Officer at Vaxcyte, Inc., Managing Director at Merrill Lynch & Co., Inc. and Managing Director at Evercore Capital Partners. She received an undergraduate degree from Wellesley College and an MBA from Harvard Business School.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
20/04/2026 23,190 ( 0% ) 83 252 $ 30/05/2026

Elaine Sun active positions

CompaniesPositionStart
RECURSION PHARMACEUTICALS, INC. Director/Board Member 14/03/2025
Director of Finance/CFO 22/03/2022
Director/Board Member 04/01/2023

Former positions of Elaine Sun

CompaniesPositionEnd
DYNAVAX TECHNOLOGIES CORPORATION Director/Board Member 09/02/2026
HALOZYME THERAPEUTICS, INC. Director of Finance/CFO 01/02/2022
VAXCYTE, INC. Director of Finance/CFO 30/11/2019
Founder -
Director/Board Member -
See the detail of Elaine Sun's experience

Training of Elaine Sun

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

12

1st degree connections

12

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies12

Finance

Health Technology

Health Technology

Health Technology

Consumer Services

Finance

Consumer Services

Health Technology

Health Technology

Technology Services

Health Technology

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!